NCT00478387已完成不适用
Study of the Immunogenicity of Killed Influenza Vaccine in Patients With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in Remission
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 37
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to determine what the immune response is of ovarian cancer patients in remission, when they are given the flu vaccine. After receiving the flu vaccine, patients will have blood drawn 5 times in 12 months to study antibody response to the flu vaccine.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •All subjects must have a histologic diagnosis of epithelial ovarian cancer or primary peritoneal carcinoma. Time from completion of chemotherapy will be no more than 6 months.
- •If no clinical evidence of disease is present after diagnosis with Stage III or IV disease and completion of primary surgery and chemotherapy, or, if no clinical evidence of disease is present after completion of chemotherapy for a disease recurrence diagnosed after a progression-free interval of at least 2 years, for patients of any initial stage.
排除标准
- •Prior malignancy (except basal cell or squamous cell skin cancer) within the past five years.
- •Presence of active CNS disease.
- •Active bacterial, viral or fungal infections.
- •Chemotherapy, biologic therapy, or radiation therapy < 4 weeks prior to study entry.
- •History of active autoimmunity or immunosuppression.
- •Use of immunosuppressive drugs within 4 weeks prior to study entry. Patients may receive chemotherapy or other immunosuppressive medications at the discretion of their physician during the subsequent year after influenza vaccination without exclusion from the study.
- •Patients with tumors of low malignant potential (borderline tumors) will not be eligible.
- •Prior influenza vaccination with the current vaccine.
- •History of serious sensitivity to eggs, or previous influenza vaccine.
- •Pregnant of breastfeeding subjects.
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr StudyOvarian NeoplasmsOvarian CarcinomaImmune SuppressionImmune System SuppressionOvarian CancerNCT06611072Gynaecologisch Oncologisch Centrum Zuid90
招募中
不适用
activating the Immune response In ovarian cancer studyovarian carcinomamalignant ovarian tumors10027656NL-OMON56684Catharina-ziekenhuis90
已完成
1 期
Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal CancerFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity CancerNCT00006041Memorial Sloan Kettering Cancer Center
已完成
不适用
Influenza Vaccination in Patients Receiving Immune Checkpoint InhibitorSolid CarcinomaInfluenzaNCT03590808Seoul National University Hospital143
已完成
不适用
The Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population.CancerNCT05033158University Hospital, Antwerp402